Quarterly report pursuant to Section 13 or 15(d)

10. Segment and Geographic Information

v3.7.0.1
10. Segment and Geographic Information
 3 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
Segment and Geographic Information

The Company generates product revenues from products which are sold into the human and animal healthcare markets, and the Company generates service revenues from laboratory testing services which are provided to medical device manufacturers. Additionally, the Company provides technical services to Invekra.

 

The following table shows the Company’s product revenues by geographic region:

 

    Three Months Ended June 30,              
    2017     2016     $ Change     % Change  
United States   $ 1,859,000     $ 1,373,000     $ 486,000       35%  
Latin America     569,000       –       569,000       100%  
Europe and Rest of the World     1,175,000       1,038,000       137,000       13%  
Total   $ 3,603,000     $ 2,411,000     $ 1,192,000       49%  

 

 

In connection with the Company’s sale of its Latin American business to Invekra, product revenues were reclassified from continuing operations to discontinued operations as follows:

 

    Three Months Ended June 30,  
    2017     2016  
Product revenues   $ –     $ 1,098,000  
Product license fees and royalties     –       75,000  
Total product related revenues   $ –     $ 1,173,000  

  

The Company’s service revenues amounted to $232,000 and $227,000 for the three months ended June 30, 2017 and 2016, respectively. During the three months ended June 30, 2017, the Company recorded service revenue related to technical services provided to Invekra in the amount of amount of $39,000.